AGP Picks
View all

Alternative Medicine Times
Provided by AGP

Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 4, 2026

Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development
Jun. 4, 2026

Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development

Indeterminate GlobeNewswire
ARKAY Beverages Launches New Brand Message: “We Don’t Sell Alcohol-Free Spirits, We Sell Happiness”
Jun. 4, 2026

ARKAY Beverages Launches New Brand Message: “We Don’t Sell Alcohol-Free Spirits, We Sell Happiness”

Indeterminate GlobeNewswire
ASKO at 3daysofdesign 2026: Precision Meets Art and Performance
Jun. 4, 2026

ASKO at 3daysofdesign 2026: Precision Meets Art and Performance

Indeterminate GlobeNewswire
Valneva Announces Availability of Documentation for its Annual General Meeting
Jun. 4, 2026

Valneva Announces Availability of Documentation for its Annual General Meeting

Indeterminate GlobeNewswire
Valneva annonce la mise à disposition de la documentation relative à son Assemblée Générale annuelle
Jun. 4, 2026

Valneva annonce la mise à disposition de la documentation relative à son Assemblée Générale annuelle

Indeterminate GlobeNewswire
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
Jun. 4, 2026

Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

Indeterminate GlobeNewswire
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
Jun. 4, 2026

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

Indeterminate GlobeNewswire
ダークホース・コンサルティング・グループとアルトゥルイスト、中国におけるバイオ医薬品の製造・開発を推進するための覚書を締結
Jun. 4, 2026

ダークホース・コンサルティング・グループとアルトゥルイスト、中国におけるバイオ医薬品の製造・開発を推進するための覚書を締結

Indeterminate GlobeNewswire
Dark Horse Consulting Group·Altruist Biologics, 중국 생물의약품 개발·생산 협력 위한 양해각서 체결
Jun. 4, 2026

Dark Horse Consulting Group·Altruist Biologics, 중국 생물의약품 개발·생산 협력 위한 양해각서 체결

Indeterminate GlobeNewswire
Dark Horse Consulting Group dan Altruist Biologics Mengumumkan Memorandum Persefahaman untuk Memajukan Pembangunan dan Pembuatan Produk Biologi di China
Jun. 4, 2026

Dark Horse Consulting Group dan Altruist Biologics Mengumumkan Memorandum Persefahaman untuk Memajukan Pembangunan dan Pembuatan Produk Biologi di China

Indeterminate GlobeNewswire
Dark Horse Consulting Group 与 Altruist Biologics 宣布签署谅解备忘录，共同推进中国生物制剂生产与开发
Jun. 4, 2026

Dark Horse Consulting Group 与 Altruist Biologics 宣布签署谅解备忘录，共同推进中国生物制剂生产与开发

Indeterminate GlobeNewswire
Dark Horse Consulting Group 與 Altruist Biologics 宣佈簽訂合作備忘錄，推動中國生物製劑的生產與開發
Jun. 4, 2026

Dark Horse Consulting Group 與 Altruist Biologics 宣佈簽訂合作備忘錄，推動中國生物製劑的生產與開發

Indeterminate GlobeNewswire
Jade Biosciences Announces Pricing of Public Offering of Common Stock
Jun. 4, 2026

Jade Biosciences Announces Pricing of Public Offering of Common Stock

Indeterminate GlobeNewswire
NCLA Reaffirms Why SCOTUS Must Mandate Review of Illegal Orders Removing Judge Newman
Jun. 4, 2026

NCLA Reaffirms Why SCOTUS Must Mandate Review of Illegal Orders Removing Judge Newman

Indeterminate GlobeNewswire
Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032
Jun. 4, 2026

Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032

Indeterminate GlobeNewswire
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
Jun. 4, 2026

BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Alternative Medicine Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.